Inventor · disambiguated record
Naphtali Reyna
Also filed as: REYNA NAPHTALI
9 granted patents·3 pending applications·27 citations·filing 2015–2025
83Inventor score
Top patents by PatentIndex Score
12 records- 0193US11713313B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2020·Granted Aug 1, 2023·3 cites·12 claims
- 0292US10738043B2GLS1 inhibitors for treating diseaseUNIV TEXAS·Filed 2018·Granted Aug 11, 2020·6 cites·12 claims
- 0391US11690850B2Inhibitors of receptor interacting protein kinase I for the treatment of diseaseUNIV TEXAS·Filed 2020·Granted Jul 4, 2023·3 cites·24 claims
- 0491US10125128B2GLS1 inhibitors for treating diseaseBOARD OF REGENTS UNIV OF TEXAS SYSTEM·Filed 2016·Granted Nov 13, 2018·13 cites·21 claims
- 0581US11753381B2Inhibitors of receptor interacting protein kinase I for the treatment of diseaseUNIV TEXAS·Filed 2020·Granted Sep 12, 2023·1 cites·8 claims
- 0680US11718612B2Inhibitors of receptor interacting protein kinase I for the treatment of diseaseUNIV TEXAS·Filed 2020·Granted Aug 8, 2023·1 cites·10 claims
- 0776US12286406B2Inhibitors of receptor interacting protein kinase I for the treatment of diseaseUNIV TEXAS·Filed 2023·Granted Apr 29, 2025·0 cites·20 claims
- 0868US2025214942A1Inhibitors of receptor interacting protein kinase i for the treatment of diseaseUNIV TEXAS·Filed 2025·Application pending·0 cites
- 0948US11046649B2Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenaseUNIV TEXAS·Filed 2019·Granted Jun 29, 2021·0 cites·23 claims
- 1042US11173145B2Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenaseUNIV TEXAS·Filed 2018·Granted Nov 16, 2021·0 cites·27 claims
- 1141US2019135793A1Heterocyclic inhibitors of kdm5 for the treatment of diseaseUNIV TEXAS·Filed 2018·Application pending·0 cites
- 1240US2016060260A1Bromodomain inhibitors for treating diseaseUNIV TEXAS·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Naphtali Reyna files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →